UBS Group’s Viking Therapeutics, Inc. VKTXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-388
| Closed | -$2K | – | 9110 |
|
|
2021
Q1 | $2K | Sell |
388
-1,523
| -80% | -$7.85K | ﹤0.01% | 7685 |
|
|
2020
Q4 | $8K | Buy |
1,911
+64
| +3% | +$268 | ﹤0.01% | 6627 |
|
|
2020
Q3 | $8K | Sell |
1,847
-971
| -34% | -$4.21K | ﹤0.01% | 6192 |
|
|
2020
Q2 | $16K | Buy |
2,818
+146
| +5% | +$829 | ﹤0.01% | 5866 |
|
|
2020
Q1 | $8K | Sell |
2,672
-222
| -8% | -$665 | ﹤0.01% | 6193 |
|
|
2019
Q4 | $19K | Sell |
2,894
-800
| -22% | -$5.25K | ﹤0.01% | 5852 |
|
|
2019
Q3 | $20K | Sell |
3,694
-400
| -10% | -$2.17K | ﹤0.01% | 5785 |
|
|
2019
Q2 | $28K | Hold |
4,094
| – | – | ﹤0.01% | 5525 |
|
|
2019
Q1 | $34K | Sell |
4,094
-5,235
| -56% | -$43.5K | ﹤0.01% | 5031 |
|
|
2018
Q4 | $57K | Buy |
9,329
+6,497
| +229% | +$39.7K | ﹤0.01% | 5088 |
|
|
2018
Q3 | $45K | Sell |
2,832
-2,248
| -44% | -$35.7K | ﹤0.01% | 5351 |
|
|
2018
Q2 | $41K | Buy |
5,080
+1,944
| +62% | +$15.7K | ﹤0.01% | 5249 |
|
|
2018
Q1 | $9K | Sell |
3,136
-312
| -9% | -$895 | ﹤0.01% | 6074 |
|
|
2017
Q4 | $9K | Buy |
+3,448
| New | +$9K | ﹤0.01% | 6145 |
|
|
2017
Q3 | – | Sell |
-232
| Closed | – | – | 6991 |
|
|
2017
Q2 | $0 | Hold |
232
| – | – | ﹤0.01% | 6969 |
|
|
2017
Q1 | $0 | Buy |
+232
| New | – | ﹤0.01% | 6931 |
|